Bazsa, I had just finished reading this announcement from Novartis re: Phase 3 trial of Jakafi when your post appeared. I read all about its possible side effects.
https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-study-jakavi-chronic-graft-versus-host-disease-met-primary-and-key-secondary-endpoints
Very interesting times ahead!
TYPE A OUTCOME AND NOVARTIS PARTNERSHIP, page-95
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.053B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $696.2K | 757.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 69420 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 152862 | 46 |
View Market Depth
| Last trade - 13.57pm 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |